| Patent | Date |
|---|
Method Of Treating A Localized Fibrotic Disorder Using An Il-33 Antagonist
App 20200338193 - Larsen; Glenn ; et al. | 2020-10-29 |
Method For Preventing Or Reducing Post-operative Cognitive Dysfunction (pocd)
App 20200123245 - Maze; Mervyn ; et al. | 2020-04-23 |
Method of treating a localized fibrotic disorder using an IL-33 antagonist
Grant 10,500,273 - Larsen , et al. Dec | 2019-12-10 |
Method Of Treating Localized Fibrotic Disorders Using An Il-33/tnf Bispecific Antibody
App 20190225682 - Nanchahal; Jagdeep ; et al. | 2019-07-25 |
Method Of Treating Systemic Fibrotic Disorders Using An Il-33/tnf Bispecific Antibody
App 20190202907 - Nanchahal; Jagdeep ; et al. | 2019-07-04 |
Method Of Treating A Localized Fibrotic Disorder Using A Tnf Receptor 2 Antagonist
App 20180036404 - Larsen; Glenn ; et al. | 2018-02-08 |
Method Of Treating A Localized Fibrotic Disorder Using An Il-33 Antagonist
App 20180030130 - Larsen; Glenn ; et al. | 2018-02-01 |
Treatment And Screening
App 20140030218 - Udalova; Irina Alexandrovna ; et al. | 2014-01-30 |
Agonists Of Toll Like Receptor For Treating Cardiovasuclar Disease And Obesity
App 20140005255 - Monaco; Claudia ; et al. | 2014-01-02 |
TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE
App 20130064816 - Feldmann; Marc ; et al. | 2013-03-14 |
Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate
Grant 8,383,120 - Feldmann , et al. February 26, 2 | 2013-02-26 |
Suppression of TNFalpha and IL-12 in therapy
App 20070178099 - Feldmann; Marc ; et al. | 2007-08-02 |
Use of cannabinoids as anti-inflammatory agents
Grant 6,410,588 - Feldmann , et al. | 2002-06-25 |
| 